Bradley John Molyneaux, M.D., M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glyburide | 8 | 2024 | 117 | 1.160 |
Why?
|
Brain Edema | 9 | 2024 | 601 | 1.010 |
Why?
|
Brain Stem Infarctions | 1 | 2023 | 31 | 0.850 |
Why?
|
Stroke | 20 | 2024 | 9755 | 0.830 |
Why?
|
Thrombectomy | 8 | 2020 | 675 | 0.820 |
Why?
|
Infarction | 1 | 2023 | 247 | 0.770 |
Why?
|
Cerebral Infarction | 4 | 2020 | 969 | 0.710 |
Why?
|
Neocortex | 3 | 2014 | 416 | 0.610 |
Why?
|
Motor Neurons | 5 | 2014 | 870 | 0.570 |
Why?
|
Gene Expression Regulation, Developmental | 7 | 2014 | 3610 | 0.530 |
Why?
|
Pyramidal Tracts | 5 | 2014 | 251 | 0.490 |
Why?
|
Blood Coagulation Factors | 1 | 2016 | 371 | 0.460 |
Why?
|
Myosins | 4 | 2000 | 408 | 0.460 |
Why?
|
Carotid Artery, Common | 1 | 2014 | 174 | 0.440 |
Why?
|
Intracranial Hemorrhages | 3 | 2018 | 809 | 0.420 |
Why?
|
Pyramidal Cells | 1 | 2014 | 367 | 0.400 |
Why?
|
Vasospasm, Intracranial | 1 | 2014 | 207 | 0.390 |
Why?
|
Cell Differentiation | 8 | 2014 | 11677 | 0.360 |
Why?
|
Brain Ischemia | 6 | 2019 | 3007 | 0.360 |
Why?
|
Neurons | 11 | 2014 | 9514 | 0.330 |
Why?
|
Corpus Callosum | 3 | 2014 | 752 | 0.330 |
Why?
|
Endarterectomy, Carotid | 1 | 2014 | 556 | 0.320 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2019 | 2815 | 0.300 |
Why?
|
Warfarin | 1 | 2016 | 1493 | 0.300 |
Why?
|
Efferent Pathways | 2 | 2008 | 165 | 0.290 |
Why?
|
Recovery of Function | 5 | 2021 | 2981 | 0.280 |
Why?
|
Software | 1 | 2019 | 4480 | 0.240 |
Why?
|
Eligibility Determination | 2 | 2019 | 421 | 0.240 |
Why?
|
Endovascular Procedures | 4 | 2018 | 2217 | 0.220 |
Why?
|
Decapodiformes | 3 | 2000 | 39 | 0.220 |
Why?
|
Patient Selection | 4 | 2019 | 4260 | 0.210 |
Why?
|
Hypoxanthine | 1 | 2022 | 28 | 0.200 |
Why?
|
Cerebral Cortex | 3 | 2008 | 5812 | 0.200 |
Why?
|
Stents | 1 | 2014 | 3197 | 0.200 |
Why?
|
Receptors, GABA-B | 1 | 2002 | 59 | 0.200 |
Why?
|
Medulla Oblongata | 1 | 2023 | 248 | 0.190 |
Why?
|
Anticoagulants | 1 | 2016 | 4850 | 0.180 |
Why?
|
Shab Potassium Channels | 1 | 2020 | 20 | 0.180 |
Why?
|
Hypoglycemic Agents | 3 | 2018 | 3109 | 0.180 |
Why?
|
Nerve Tissue Proteins | 6 | 2014 | 4413 | 0.170 |
Why?
|
Nervous System Diseases | 2 | 2022 | 1662 | 0.170 |
Why?
|
Theta Rhythm | 1 | 2002 | 222 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20762 | 0.170 |
Why?
|
Presynaptic Terminals | 1 | 2002 | 302 | 0.170 |
Why?
|
RNA, Messenger | 1 | 2014 | 12801 | 0.170 |
Why?
|
Mannitol | 1 | 2020 | 176 | 0.170 |
Why?
|
Saline Solution, Hypertonic | 1 | 2020 | 115 | 0.170 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 2020 | 120 | 0.160 |
Why?
|
Middle Cerebral Artery | 1 | 2020 | 271 | 0.150 |
Why?
|
Spinal Cord | 1 | 2007 | 1812 | 0.150 |
Why?
|
Comprehensive Health Care | 1 | 2019 | 123 | 0.150 |
Why?
|
Intracranial Thrombosis | 1 | 2019 | 107 | 0.150 |
Why?
|
Remote Consultation | 1 | 2021 | 242 | 0.150 |
Why?
|
Patient Transfer | 3 | 2024 | 792 | 0.150 |
Why?
|
Neural Inhibition | 1 | 2002 | 588 | 0.150 |
Why?
|
Heart Arrest | 2 | 2019 | 1515 | 0.150 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2019 | 158 | 0.150 |
Why?
|
Stem Cells | 2 | 2008 | 3538 | 0.150 |
Why?
|
Hospice Care | 1 | 2024 | 678 | 0.140 |
Why?
|
Carotid Artery, Internal | 1 | 2020 | 440 | 0.140 |
Why?
|
Emergency Service, Hospital | 3 | 2024 | 7951 | 0.140 |
Why?
|
Cerebrum | 1 | 2018 | 132 | 0.140 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2020 | 485 | 0.130 |
Why?
|
Shock, Hemorrhagic | 1 | 2018 | 224 | 0.130 |
Why?
|
DNA-Binding Proteins | 3 | 2014 | 9617 | 0.130 |
Why?
|
Fluid Therapy | 1 | 2020 | 587 | 0.130 |
Why?
|
Shivering | 1 | 2015 | 11 | 0.130 |
Why?
|
Myoclonus | 1 | 2016 | 107 | 0.130 |
Why?
|
Neuroprotective Agents | 2 | 2020 | 958 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 3 | 2014 | 2810 | 0.130 |
Why?
|
Ischemic Attack, Transient | 1 | 2021 | 877 | 0.120 |
Why?
|
International Normalized Ratio | 1 | 2016 | 382 | 0.120 |
Why?
|
Repressor Proteins | 3 | 2014 | 2982 | 0.120 |
Why?
|
Disability Evaluation | 2 | 2021 | 1835 | 0.120 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2014 | 48 | 0.120 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2015 | 92 | 0.120 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2018 | 340 | 0.120 |
Why?
|
Nitriles | 1 | 2020 | 980 | 0.120 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2016 | 183 | 0.110 |
Why?
|
Rett Syndrome | 1 | 2016 | 164 | 0.110 |
Why?
|
Aged, 80 and over | 10 | 2024 | 59626 | 0.110 |
Why?
|
Patient Admission | 2 | 2021 | 1365 | 0.110 |
Why?
|
In Situ Hybridization | 2 | 2009 | 1904 | 0.110 |
Why?
|
Pulvinar | 1 | 2013 | 24 | 0.110 |
Why?
|
Middle Aged | 22 | 2024 | 223487 | 0.110 |
Why?
|
Aged | 20 | 2024 | 171502 | 0.110 |
Why?
|
Water | 1 | 2019 | 1421 | 0.110 |
Why?
|
Animals | 22 | 2022 | 169285 | 0.100 |
Why?
|
Cerebral Hemorrhage | 1 | 2024 | 2654 | 0.100 |
Why?
|
Phylogeny | 1 | 2000 | 2843 | 0.100 |
Why?
|
NF-kappa B | 2 | 2022 | 2494 | 0.100 |
Why?
|
Bromodeoxyuridine | 3 | 2008 | 310 | 0.100 |
Why?
|
Electroencephalography | 2 | 2018 | 6314 | 0.100 |
Why?
|
Functional Laterality | 1 | 2018 | 2264 | 0.100 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2019 | 997 | 0.100 |
Why?
|
Cerebral Angiography | 1 | 2017 | 1264 | 0.100 |
Why?
|
Mice | 14 | 2022 | 82049 | 0.090 |
Why?
|
Tissue and Organ Procurement | 1 | 2019 | 986 | 0.090 |
Why?
|
Dexmedetomidine | 1 | 2015 | 320 | 0.090 |
Why?
|
Male | 26 | 2024 | 364731 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2057 | 0.090 |
Why?
|
Humans | 36 | 2024 | 768171 | 0.090 |
Why?
|
Female | 26 | 2024 | 397187 | 0.090 |
Why?
|
Neurotransmitter Agents | 1 | 2014 | 663 | 0.090 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 17623 | 0.090 |
Why?
|
Hypothermia, Induced | 1 | 2015 | 754 | 0.090 |
Why?
|
Cerebrovascular Circulation | 1 | 2020 | 2725 | 0.080 |
Why?
|
Tissue Donors | 1 | 2019 | 2381 | 0.080 |
Why?
|
Brain | 4 | 2022 | 27362 | 0.080 |
Why?
|
Antibodies | 1 | 1997 | 2421 | 0.080 |
Why?
|
Mice, Inbred C57BL | 7 | 2022 | 22380 | 0.080 |
Why?
|
Inpatients | 1 | 2021 | 2566 | 0.080 |
Why?
|
Molecular Motor Proteins | 2 | 2000 | 106 | 0.080 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3728 | 0.080 |
Why?
|
Nerve Degeneration | 1 | 2013 | 749 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2830 | 0.080 |
Why?
|
Neural Pathways | 3 | 2009 | 3117 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15453 | 0.080 |
Why?
|
Retrospective Studies | 12 | 2021 | 81760 | 0.080 |
Why?
|
Animals, Newborn | 4 | 2008 | 2683 | 0.080 |
Why?
|
Neurogenesis | 1 | 2014 | 864 | 0.080 |
Why?
|
In Situ Nick-End Labeling | 2 | 2008 | 611 | 0.070 |
Why?
|
Syndrome | 1 | 2014 | 3273 | 0.070 |
Why?
|
Status Epilepticus | 1 | 2013 | 463 | 0.070 |
Why?
|
Time Factors | 8 | 2021 | 40220 | 0.070 |
Why?
|
Hypnotics and Sedatives | 1 | 2015 | 1191 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 11930 | 0.070 |
Why?
|
Cell Surface Extensions | 1 | 2007 | 66 | 0.070 |
Why?
|
Green Fluorescent Proteins | 3 | 2008 | 2065 | 0.070 |
Why?
|
Embryo, Mammalian | 3 | 2008 | 1676 | 0.070 |
Why?
|
Genes, Homeobox | 1 | 2007 | 289 | 0.060 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2005 | 29 | 0.060 |
Why?
|
POU Domain Factors | 1 | 2005 | 47 | 0.060 |
Why?
|
Seizures | 1 | 2018 | 2998 | 0.060 |
Why?
|
Annexin A2 | 1 | 2005 | 43 | 0.060 |
Why?
|
Treatment Outcome | 9 | 2024 | 65379 | 0.060 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2005 | 128 | 0.060 |
Why?
|
Cell Cycle Proteins | 2 | 2008 | 3445 | 0.060 |
Why?
|
Cell Count | 2 | 2008 | 1832 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15949 | 0.060 |
Why?
|
S100 Proteins | 1 | 2005 | 216 | 0.060 |
Why?
|
Basal Ganglia Hemorrhage | 1 | 2024 | 8 | 0.060 |
Why?
|
Growth Cones | 1 | 2005 | 117 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2014 | 5902 | 0.060 |
Why?
|
Coma | 2 | 2018 | 485 | 0.060 |
Why?
|
Base Sequence | 1 | 2014 | 12422 | 0.060 |
Why?
|
Carrier Proteins | 2 | 2008 | 4939 | 0.050 |
Why?
|
Mice, Knockout | 5 | 2016 | 14488 | 0.050 |
Why?
|
Radiography | 1 | 2014 | 6986 | 0.050 |
Why?
|
Genetic Markers | 1 | 2009 | 2603 | 0.050 |
Why?
|
Neuroendoscopy | 1 | 2024 | 100 | 0.050 |
Why?
|
Phosphinic Acids | 1 | 2002 | 17 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2024 | 12466 | 0.050 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1143 | 0.050 |
Why?
|
GABA Antagonists | 1 | 2002 | 119 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2008 | 5804 | 0.050 |
Why?
|
Signal Transduction | 2 | 2016 | 23648 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8616 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2005 | 812 | 0.050 |
Why?
|
Propanolamines | 1 | 2002 | 164 | 0.050 |
Why?
|
Corpus Striatum | 1 | 2008 | 1224 | 0.050 |
Why?
|
Optic Lobe, Nonmammalian | 2 | 1998 | 14 | 0.050 |
Why?
|
Thalamus | 1 | 2008 | 1047 | 0.050 |
Why?
|
Second Messenger Systems | 1 | 2002 | 203 | 0.050 |
Why?
|
Motor Cortex | 2 | 2008 | 1013 | 0.050 |
Why?
|
Nerve Regeneration | 1 | 2007 | 797 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9540 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 1151 | 0.040 |
Why?
|
Cell Death | 1 | 2005 | 1680 | 0.040 |
Why?
|
Adult | 9 | 2024 | 223646 | 0.040 |
Why?
|
Decompressive Craniectomy | 1 | 2020 | 76 | 0.040 |
Why?
|
Rotarod Performance Test | 1 | 2019 | 63 | 0.040 |
Why?
|
Endoplasmic Reticulum, Smooth | 1 | 1998 | 4 | 0.040 |
Why?
|
Amino Acids | 1 | 2005 | 1716 | 0.040 |
Why?
|
Osmolar Concentration | 1 | 2020 | 657 | 0.040 |
Why?
|
Sequence Analysis, Protein | 1 | 2000 | 264 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2008 | 2892 | 0.040 |
Why?
|
Egg Proteins | 1 | 1998 | 58 | 0.040 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2022 | 634 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2000 | 13422 | 0.040 |
Why?
|
Length of Stay | 2 | 2024 | 6498 | 0.040 |
Why?
|
Sequence Alignment | 2 | 2000 | 2179 | 0.040 |
Why?
|
Infusions, Subcutaneous | 1 | 2018 | 43 | 0.040 |
Why?
|
Neuronal Plasticity | 1 | 2007 | 1448 | 0.040 |
Why?
|
Membrane Glycoproteins | 2 | 2008 | 3713 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2023 | 36741 | 0.040 |
Why?
|
Stilbamidines | 2 | 2008 | 43 | 0.040 |
Why?
|
Phenotype | 1 | 2016 | 16726 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2005 | 1625 | 0.040 |
Why?
|
Cell Lineage | 1 | 2007 | 2575 | 0.040 |
Why?
|
Pennsylvania | 1 | 2019 | 615 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2000 | 930 | 0.040 |
Why?
|
Cell Movement | 2 | 2008 | 5213 | 0.040 |
Why?
|
Mice, Transgenic | 4 | 2014 | 9561 | 0.040 |
Why?
|
Glasgow Outcome Scale | 1 | 2017 | 101 | 0.030 |
Why?
|
Transcription Factors | 2 | 2014 | 12171 | 0.030 |
Why?
|
Brain Chemistry | 1 | 2000 | 958 | 0.030 |
Why?
|
Brain Death | 1 | 2019 | 359 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15833 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2005 | 2430 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2018 | 1379 | 0.030 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2016 | 75 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2024 | 2359 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2018 | 592 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2002 | 1141 | 0.030 |
Why?
|
Vascular System Injuries | 1 | 2018 | 248 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2017 | 574 | 0.030 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 419 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2000 | 4168 | 0.030 |
Why?
|
Genes, Suppressor | 1 | 2014 | 47 | 0.030 |
Why?
|
Intracranial Pressure | 1 | 2017 | 323 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1998 | 2300 | 0.030 |
Why?
|
Information Services | 1 | 1995 | 239 | 0.030 |
Why?
|
Mutation | 1 | 1998 | 30237 | 0.030 |
Why?
|
Protein Isoforms | 1 | 1998 | 1715 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8052 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1643 | 0.030 |
Why?
|
Young Adult | 4 | 2024 | 60066 | 0.030 |
Why?
|
Protein Conformation | 1 | 2000 | 3956 | 0.030 |
Why?
|
Models, Biological | 2 | 2007 | 9497 | 0.030 |
Why?
|
Terminal Care | 1 | 2024 | 1770 | 0.020 |
Why?
|
Body Temperature | 1 | 2015 | 780 | 0.020 |
Why?
|
Telephone | 1 | 1995 | 630 | 0.020 |
Why?
|
Postoperative Care | 1 | 2018 | 1480 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11095 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2000 | 1896 | 0.020 |
Why?
|
Hospitalization | 2 | 2024 | 10840 | 0.020 |
Why?
|
Rabbits | 1 | 1997 | 4773 | 0.020 |
Why?
|
Actins | 1 | 1998 | 2064 | 0.020 |
Why?
|
Aftercare | 1 | 2017 | 916 | 0.020 |
Why?
|
Fever | 1 | 2018 | 1614 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2000 | 6082 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8142 | 0.020 |
Why?
|
Anesthesia | 1 | 2002 | 1596 | 0.020 |
Why?
|
Prospective Studies | 3 | 2020 | 54924 | 0.020 |
Why?
|
Triage | 1 | 2017 | 997 | 0.020 |
Why?
|
Models, Molecular | 1 | 2000 | 5402 | 0.020 |
Why?
|
HIV Seropositivity | 1 | 1995 | 966 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2018 | 1388 | 0.020 |
Why?
|
Hippocampus | 1 | 2002 | 3783 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18349 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3628 | 0.020 |
Why?
|
Quality Improvement | 1 | 2024 | 3857 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2018 | 1923 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2017 | 22290 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8316 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2013 | 1836 | 0.020 |
Why?
|
Age Factors | 1 | 2005 | 18415 | 0.020 |
Why?
|
Family | 1 | 2019 | 3209 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2005 | 7876 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8542 | 0.020 |
Why?
|
Receptor, Muscarinic M4 | 1 | 2008 | 16 | 0.020 |
Why?
|
Telencephalon | 1 | 2008 | 143 | 0.020 |
Why?
|
SOXD Transcription Factors | 1 | 2008 | 44 | 0.020 |
Why?
|
Adolescent | 3 | 2024 | 89169 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2018 | 2100 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8741 | 0.020 |
Why?
|
Electroporation | 1 | 2008 | 239 | 0.020 |
Why?
|
Patient Readmission | 1 | 2021 | 3288 | 0.020 |
Why?
|
Fear | 1 | 1995 | 1493 | 0.020 |
Why?
|
Rats | 1 | 2002 | 23782 | 0.020 |
Why?
|
Contrast Media | 1 | 2018 | 5330 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2008 | 753 | 0.010 |
Why?
|
Somatosensory Cortex | 1 | 2008 | 516 | 0.010 |
Why?
|
Superior Colliculi | 1 | 2005 | 97 | 0.010 |
Why?
|
Body Patterning | 1 | 2008 | 634 | 0.010 |
Why?
|
Heart Rate | 1 | 2015 | 4214 | 0.010 |
Why?
|
Blood Glucose | 1 | 2018 | 6431 | 0.010 |
Why?
|
Mitosis | 1 | 2008 | 1178 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5797 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8080 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2008 | 1750 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8375 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15869 | 0.010 |
Why?
|
Nerve Growth Factors | 1 | 2005 | 564 | 0.010 |
Why?
|
Health Personnel | 1 | 1995 | 3384 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21538 | 0.010 |
Why?
|
Blood Pressure | 1 | 2015 | 8543 | 0.010 |
Why?
|
ras Proteins | 1 | 2005 | 1058 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 1998 | 323 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 13490 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3806 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 30009 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2748 | 0.010 |
Why?
|
Species Specificity | 1 | 1998 | 2415 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 1998 | 1083 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1998 | 2004 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74944 | 0.010 |
Why?
|
Pregnancy | 1 | 2008 | 30255 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1998 | 9262 | 0.000 |
Why?
|